Evidence map›Paper›PMID 39470939›Full record

ReviewInternational urology and nephrology2025

Comprehensive assessment in uro-oncologic geriatric patients: interdisciplinary management to improve survival.

José Mauricio Ocampo Chaparro, Daniel Andrés Nieva-Posso, Herney Andrés García-Perdomo

Abstract readReview
PubMed Publisher
In one paragraph

Review in International urology and nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

José Mauricio Ocampo ChaparroDepartment of Family Medicine. School of Medicine, Universidad del Valle, Cali, Colombia.
Daniel Andrés Nieva-PossoUROGIV. Group Research. School of Medicine, Universidad del Valle, Calle 4 B # 36-00, Cali, Colombia.
Herney Andrés García-PerdomoUROGIV. Group Research. School of Medicine, Universidad del Valle, Calle 4 B # 36-00, Cali, Colombia. herney.garcia@correounivalle.edu.co.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urological cancers represent 13.1% of cancer cases in the world, with a mean age of diagnosis of 67 years, making it a geriatric disease. The lack of participation and evaluation of treatments by the geriatric oncologic population has made their mortality rate higher than that of other oncologic population groups, urologic cancers being no exception. The comprehensive management of older people with urological cancers is a bet that is presented to improve the quality of life and survival of this group. Managing elements such as nutritional, physical, cognitive, psychosocial, and sexual status improves the chances of adherence and treatment, contributing significantly to improving the quality of life. The integrated management of the geriatric oncology population has brought positive effects on quality of life, enhancing levels of depression and anxiety and also allowing the classification of oncology patients based on other criteria in addition to their chronologic age, contributing to the management of specialized treatments that have allowed the implementation of more specific interventions with better results.

Indexed as

Geriatric AssessmentPatient Care TeamUrologic NeoplasmsAgedHumansQuality of LifeSurvival RateGeriatric assessmentGeriatric oncologyOlder adult with cancerUrologic neoplasms

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.